Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen Systems

Ehringer, H., Hornykiewicz, O.·1960·Klinische Wochenschrift

DOI 10.1007/bf01485901

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/bf01485901

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

No references could be resolved yet.

Research works printed but not linked: 25

Bertler, A., A. Carlsson andE. Rosengren: Fysiogr. Sällsk. Handl.28, 121 (1958).
Bertler, A., B. Falk, A. Hillarp, E. Rosengren andA. Torp: Acta physiol. scand.47, 251 (1959). · doi:10.1111/j.1748-1716.1960.tb00075.x
Bertler, A., andE. Rosengren: Experientia (Basel)15, 10 (1959). · doi:10.1007/bf02157069
Bertler, A., andE. Rosengren: Experietia15, 382 (1959a). · DOI · Paper page
Carlsson, A., M. Lindquist andT. Magnusson: Nature (Lund.)180, 1200 (1957). · DOI · Paper page
Carlsson, A., M. Lindquist, T. Magnusson andB. Waldeck: Science127, 471 (1958). · DOI · Paper page
Demis, D. J., H. Blaschko andA. D. Welch: J. Pharmacol.117, 208 (1955).
Eade, N. R.: J. Physiol (Lond.)141, 183 (1958). · doi:10.1113/jphysiol.1958.sp005966
Euler, U. S. v.: Acta physiol. scand.12, 73 (1946). · DOI · Paper page
Euler, U. S. v., u.I. Floding: Acta physiol. scand.33, Suppl. 118, 57 (1955).
Euler, U. S. v., andU. Hamberg: Acta physiol. scand.19, 74 (1949). · doi:10.1111/j.1748-1716.1949.tb00636.x
Gunn, J. A.: Arch. int. Pharmacodyn.50, 379 (1935).
Hagen, P.: J. Pharmacol.116, 26 (1956).
Hagen, P., andA. Welch: Recent. Progr. Hormone Res.12, 27 (1955).
Holtz, P.: Acta physiol. scand.20, 354 (1950). · doi:10.1111/j.1748-1716.1950.tb00712.x
Holzer, G., andO. Hornykiewicz: Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak.237, 27 (1959). · doi:10.1007/bf00244557
Montagu, K. A.: Nature (Lond.)180, 244 (1957). · DOI · Paper page
Sano, I., T. Gamo, Y. Kakimoto, K. Taniguchi, M. Takesada andK. Nishinuma: Biochim. biophys. Acta32, 586 (1959). · DOI · Paper page
Schaepdryver, A. F. de: Arch. int. Pharmacodyn.115, 233 (1958).
Shimizu, N., andN. Morikawa: Nature (Lond.)184, 650 (1959). · doi:10.1038/184650b0
Spatz, H.: Anat. Anz., Erg.-Bd.60, 54 (1925).
Klauee, R.: Arch. Psychiat. Nervenkr.111, 251 (1940). · DOI
Udenfriend, S., andC. R. Creveling: J. Neurochem.4, 350 (1959). · doi:10.1111/j.1471-4159.1959.tb13216.x
Vogt, Marthe: J. Physiol. (Lond.)123, 451 (1954). · DOI · Paper page
Weil-Malherbe, H., andA. D. Bone: Nature180, 1050 (1957). · doi:10.1038/1801050a0

Stereotaxic mapping of the monoamine pathways in the rat brain
Ungerstedt, U. (1971) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.1971.tb10998.x · Cited by 3,819
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476
Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia
Grace, A. A. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90196-u · Cited by 1,831
100 years of Lewy pathology
Goedert, M., Spillantini, M. G., Del Tredici, K., & Braak, H. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.242 · Cited by 1,190
Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease
Redgrave, P., Rodriguez, M., Smith, Y., Rodriguez-Oroz, M. C., Lehericy, S., Bergman, H., Agid, Y., DeLong, M. R., & Obeso, J. A. (2010) · Nature reviews. Neuroscience · doi:10.1038/nrn2915 · Cited by 1,134
Huntington's Chorea: Deficiency of γ-Aminobutyric Acid in Brain
Perry, T. L., Hansen, S., & Kloster, M. (1973) · New England Journal of Medicine · doi:10.1056/nejm197302152880703 · Cited by 833
Molecular Diversity of the Dopamine Receptors
Civelli, O., Bunzow, J. R., & Grandy, D. K. (1993) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.33.040193.001433 · Cited by 623
Dopamine Receptors in the Brain: A dopamine-sensitive adenylate cyclase models synaptic receptors, illuminating antipsychotic drug action.
Iversen, L. L. (1975) · Science · doi:10.1126/science.2976 · Cited by 527
Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies
Bezard, E., Brotchie, J. M., & Gross, C. E. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086062 · Cited by 503
Alpha-synuclein in colonic submucosa in early untreated Parkinson’s disease
Shannon, K. M., Keshavarzian, A., Mutlu, E., Dodiya, H. B., Daian, D., Jaglin, J. A., & Kordower, J. H. (2012) · Movement Disorders · doi:10.1002/mds.23838 · Cited by 469
The History of Parkinson's Disease: Early Clinical Descriptions and Neurological Therapies
Goetz, C. G. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a008862 · Cited by 470
Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts
Jellinger, K. A. (2012) · Movement Disorders · doi:10.1002/mds.23795 · Cited by 451
Motor Responses to Sudden Limb Displacements in Primates with Specific CNS Lesions and in Human Patients with Motor System Disorders
Lee, R. G., & Tatton, W. G. (1975) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100020382 · Cited by 441
The place of dopamine in the cortico-basal ganglia circuit
Haber, S. N. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.008 · Cited by 364
Cholinergic-Anticholinergic Antagonism in Parkinsonism
Duvoisin, R. C. (1967) · Archives of Neurology · doi:10.1001/archneur.1967.00470260014002 · Cited by 342
Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease
Teismann, P., & Ferger, B. (2001) · Synapse · doi:10.1002/1098-2396(200102)39:2<167::aid-syn8>3.0.co;2-u · Cited by 306
Neurochemical findings in the MPTP model of Parkinson's disease
Schmidt, N., & Ferger, B. (2001) · Journal of Neural Transmission · doi:10.1007/s007020100004 · Cited by 290
Levodopa in Parkinson’s Disease: Current Status and Future Developments
Tambasco, N., Romoli, M., & Calabresi, P. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170510143821 · Cited by 282
Aging Produces a Specific Pattern of Striatal Dopamine Loss: Implications for the Etiology of Idiopathic Parkinson's Disease
Kish, S. J., Shannak, K., Rajput, A., Deck, J. H. N., & Hornykiewicz, O. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09766.x · Cited by 272
Self-citation
Estrogen Is Essential for Maintaining Nigrostriatal Dopamine Neurons in Primates: Implications for Parkinson's Disease and Memory
Leranth, C., Roth, R. H., Elsworth, J. D., Naftolin, F., Horvath, T. L., & Redmond, D. E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08604.2000 · Cited by 271
Tyrosine Hydroxylase and Parkinson’s Disease
Haavik, J., & Toska, K. (1998) · Molecular Neurobiology · doi:10.1007/bf02741387 · Cited by 263
The pathophysiology of parkinsonian tremor: a review
Deuschl, G., Raethjen, J., Baron, R., Lindemann, M., Wilms, H., & Krack, P. (2000) · Journal of Neurology · doi:10.1007/pl00007781 · Cited by 251
Striatal mechanisms underlying movement, reinforcement, and punishment
Kravitz, A. V., & Kreitzer, A. C. (2012) · Physiology · doi:10.1152/physiol.00004.2012 · Cited by 224
The organization of midbrain projections to the striatum in the primate: sensorimotor-related striatum versus ventral striatum
Lynd-Balta, E., & Haber, S. N. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90182-1 · Cited by 233
Levodopa in the treatment of Parkinson's disease
Schapira, A. H. V., Emre, M., Jenner, P., & Poewe, W. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02697.x · Cited by 231
Long term motor complications of levodopa: clinical features, mechanisms, and management strategies
Thanvi, B. R., & Lo, T. C. N. (2004) · Postgraduate Medical Journal · doi:10.1136/pgmj.2003.013912 · Cited by 194
Reduced intravenous glutathione in the treatment of early parkinson's disease
Sechi, G., Deledda, M. G., Bua, G., Satta, W. M., Deiana, G. A., Pes, G. M., & Rosati, G. (1996) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(96)00103-0 · Cited by 173
The activity of pars compacta neurons of the monkey substantia nigra in relation to motor activation
Schultz, W., Ruffieux, A., & Aebischer, P. (1983) · Experimental Brain Research · doi:10.1007/bf00237874 · Cited by 136
An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition
Members, E. W. E., Terron, A., Bal-Price, A., Paini, A., Monnet-Tschudi, F., Bennekou, S. H., Leist, M., & Schildknecht, S. (2018) · Archives of Toxicology · doi:10.1007/s00204-017-2133-4 · Cited by 124
SK channels control the firing pattern of midbrain dopaminergic neurons in vivo
Waroux, O., Massotte, L., Alleva, L., Graulich, A., Thomas, E., Liégeois, J., Scuvée‐Moreau, J., & Seutin, V. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04484.x · Cited by 103
Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum
Ichitani, Y., Okamura, H., Matsumoto, Y., Nagatsu, I., & Ibata, Y. (1991) · Brain Research · doi:10.1016/0006-8993(91)90481-a · Cited by 96
Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: Implications for Parkinson’s disease
Ossowska, K., Śmiałowska, M., Kuter, K., Wierońska, J., Zięba, B., Wardas, J., Nowak, P., Dąbrowska, J., Bortel, A., Biedka, I., et al. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.05.039 · Cited by 84
Regulation of the neurodegenerative process associated to Parkinson's disease by CD4+ T-cells
González, H., Contreras, F., & Pacheco, R. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9618-9 · Cited by 70
Schizophrenic psychology, associative learning and the role of forebrain dopamine
Miller, R. (1976) · Medical Hypotheses · doi:10.1016/0306-9877(76)90040-2 · Cited by 67
The emerging role of retromer in neuroprotection
McMillan, K. J., Korswagen, H. C., & Cullen, P. J. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.02.004 · Cited by 66
D1 and D5 dopamine receptors participate on the consolidation of two different memories
Furini, C. R. G., Myskiw, J. C., Schmidt, B. E., Marcondes, L. A., & Izquierdo, I. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.06.027 · Cited by 60
Fasudil, a Rho kinase inhibitor, promotes the autophagic degradation of A53T α-synuclein by activating the JNK 1/Bcl-2/beclin 1 pathway
Liu, F.-T., Yang, Y.-J., Wu, J.-J., Li, S., Tang, Y.-L., Zhao, J., Liu, Z.-Y., Xiao, B.-G., Zuo, J., Liu, W., et al. (2016) · Brain Research · doi:10.1016/j.brainres.2015.12.002 · Cited by 39
Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys
Masilamoni, G. J., Groover, O., & Smith, Y. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.12.025 · Cited by 37
Treatment of Parkinson's disease with NADH
Dizdar, N., Kågedal, B., & Lindvall, B. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1994.tb02735.x · Cited by 20
Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats
Konieczny, J., Lenda, T., & Czarnecka, A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.02.072 · Cited by 12

Authors: Ehringer, H., & Hornykiewicz, O.
Venue: Klinische Wochenschrift
Publisher: Springer Science and Business Media LLC
Published: 1960-12
Volume: 38
Issue: 24
Pages: 1236-1239
ISSN: 0946-2716 (ISSN-L)
0023-2173
1432-1440
DOI: 10.1007/bf01485901
OpenAlex: W175006040
Cited by: 1,867
References: 0
FWCI: 9.89
Type: journal article
Language: de
Open access: closed
Licence: www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen Systems

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources